Donate
T1International team members and other advocates for affordable insulin participate in a campaign outside the Eli Lilly headquarters, where much of the US insulin supply is made, in Indianapolis, IN on Monday, October 24, 2022. T1I, is a non-profit advocacy organization founded by Elizabeth Pfiester who has had Type 1 diabetes since she was a child. Pfiester and her team, people with and impacted by type 1 diabetes, are working to achieve affordable insulin prices for all, no matter where a patient lives. © Photo by Erin Lubin

What We Do

Building power for insulin access worldwide.

At T1International, we work to ensure that everyone with diabetes has dignity and that no one has to rely on unpredictable and unstable donations of insulin or diabetes supplies. 

Our Campaigns

Group of people marching past a Lily building

Taking on Monopoly Power

  • Public Pharma
  • Patent Reform
Read more: Taking on Monopoly Power
Insulin novo

Insulin Access

  • Alec’s Law and Emergency Access to Insulin
  • Kevin’s Law and Expanding Pharmacist Scope of Practice
  • Insulin Price Caps
  • Modern Insulin Access
Read more: Insulin Access
Speaking at a group of people at a film screening in Sierra Leone

Demanding Full Care Access

  • Glucose self-monitoring supplies
  • Essential Medicines and Universal Health Coverage
  • Diabetes in humanitarian settings
  • Mental health care
  • Education and Ending Discrimination
Read more: Demanding Full Care Access

We uncover the truth about the diabetes crisis by collecting and amplifying the real experiences of people affected by high costs, systemic neglect and corporate greed

We imagine and work to build new systems and structures where access to essential medicines like insulin are human rights and where everyone can access the care, medicines, and supplies they need.

Round graphic in yellow, green, red, and purple with arrows to each other saying: "Inform" "Reform" "Confront" "Transform" with "How we work" in the middle
See Our Impact and Our Plan

We advocate for improving laws, policies and institutions that make diabetes care affordable.

We tackle the root cause of inequity in diabetes care by holding corporations and the government accountable for their greed and policies that endanger lives.

Stay up to date with our Newsletter

Campaign wins, new resources, and ways to take action — straight to your inbox every month.